## CVX: Chevron Corporation - XLE: Energy

### Executive Summary

No thesis match: MRS_20 -2.1% below STRENGTH zone (4.0-10.0%); PEG 2.94 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($146.17)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Chevron (CVX) director reports 296 phantom stock units and 19,840 total derivatives**
- Source: Stock Titan | 20251203T190400 | Neutral | Relevance: 100%
- A director at Chevron Corporation (CVX) reported an acquisition of 296 phantom stock units on December 1, 2025, under the company's Non-Employee Directors' Equity Compensation and Deferral Plan. These phantom units are convertible into common stock on a 1-for-1 basis when the director's board service concludes. Following this transaction, the director's beneficial ownership of derivative securities tied to Chevron common stock increased to 19,840, including dividend equivalent accruals.

**2. Chevron sets 2026 capital budget at $18-19 billion, focuses on US**
- Source: Investing.com | 20251203T180500 | Somewhat-Bullish | Relevance: 100%
- Chevron has announced its 2026 organic capital expenditure budget will be $18-19 billion, with a significant focus on U.S. operations, particularly in the upstream segment. The company plans to allocate over half of the budget to U.S. activities and invest in lowering carbon intensity and new energy businesses. This disciplined capital allocation strategy aims to grow cash flow and earnings while maintaining a strong dividend yield and balancing investments with shareholder returns.

**3. Chevron (NYSE: CVX) maps 2026 $18-$19B capex with $10.5B U.S. spend**
- Source: Stock Titan | 20251203T180000 | Neutral | Relevance: 100%
- Chevron announced its 2026 capital expenditure (capex) budget ranging from $18 billion to $19 billion, with over half, approximately $10.5 billion, allocated to U.S. operations. This budget, at the low end of their long-term guidance, focuses on high-return opportunities, including significant investment in U.S. shale & tight assets and global offshore projects. The company aims to grow cash flow and earnings, while also dedicating $1 billion to lowering carbon intensity and developing new energy businesses.

**4. UBS reiterates Buy rating on Chevron stock with $197 price target**
- Source: Investing.com | 20251202T080300 | Bullish | Relevance: 100%
- UBS has reiterated its Buy rating on Chevron (NYSE:CVX) with a price target of $197.00, following the company's expansion in Nigerian offshore exploration. This target represents a nearly 30% upside from Chevronâ€™s current price, with the energy giant trading below its InvestingPro Fair Value. The move also highlights Chevron's potential for strong free cash flow growth.

**5. Chevron Joins TotalEnergies in New Nigerian Exploration Blocks**
- Source: Rigzone | 20251202T063000 | Bullish | Relevance: 100%
- Chevron has agreed to acquire a 40 percent stake in Petroleum Prospecting Licenses (PPL) 2000 and 2001 offshore Nigeria from TotalEnergies, which will maintain operatorship. This joint venture aims to derisk and develop new opportunities in Nigeria, aligning with the country's objectives, and follows TotalEnergies' acquisition of stakes in US offshore exploration leases from Chevron earlier this year. The Nigerian blocks, PPL 2000 and PPL 2001, are part of the Niger Delta lobe, with PPL 2000 having two previously drilled wells and PPL 2001 remaining undrilled but showing potential.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 5, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-01 | HSBC | $169 | $166 | +2% |
| 2025-11-14 | Wells Fargo | $196 | $190 | +3% |
| 2025-11-13 | Piper Sandler | $168 | $169 | -1% |
| 2025-11-13 | Mizuho | $204 | $191 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-01 | HSBC | up | Buy |
| 2025-11-14 | Wells Fargo | main | Overweight |
| 2025-11-13 | Piper Sandler | main | Overweight |
| 2025-11-13 | Mizuho | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.86M) |
| Sells | 3 ($37.80M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 9 / 0 |

**Top Holders:**
- Vanguard Group Inc: 9.1% (+17.9%)
- State Street Corpora: 7.6% (+9.2%)
- Blackrock Inc.: 6.9% (+16.9%)
- Berkshire Hathaway, : 6.1% (0.0%)
- Geode Capital Manage: 2.2% (+18.0%)

### Key Risks

1. Heavy insider selling: $38M sold (3 transactions in 90 days).
2. Valuation risk: PEG 2.9x with declining EPS estimates leaves no margin for error.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 5 raises (avg +3%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.94 signals overvaluation risk, limited margin of safety. Forward P/E 20.1x stretched relative to 3% growth. Balance sheet: $4.7B free cash flow. Insider selling cluster ($37.8M in 90 days), potential headwind. Institutional flow bullish (9 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $302.3B |
| Beta | 0.67 |
| 52W Range | $132.04 - $168.96 |
| Short Interest | 0.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.94 |
| Forward P/E | 20.1 |
| Current P/E | 20.7 |
| YoY Growth | 2.9% |
| EPS Direction | FALLING |

### Technicals

MRS_20 stable at -2.1% (minimal 5-day change). Below STRENGTH zone by 6.1pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.00x) but short-term weakness (below SMA20). RSI neutral at 47. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.06% (CS: 29) | Weak |
| RSI_14 | 47.4 | Neutral |
| MACD Histogram | -0.09 | Bearish |
| vs SMA20 | 0.993x | Below |
| vs SMA50 | 0.986x | Below |
| vs SMA200 | 1.005x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $151.59
- **Stop Loss:** $146.17 (3.6% risk)
- **Target:** $157.01 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 175
- **Position Value:** $26,528.25
- **Portfolio %:** 26.53%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-01-30 (Est: $1.57)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.71 | $1.85 | +8.4% |
| 2025Q2 | $1.74 | $1.77 | +1.7% |
| 2025Q1 | $2.15 | $2.18 | +1.3% |
| 2024Q4 | $2.11 | $2.06 | -2.3% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*